Trial Profile
Effects of moxonidine in hypertensive patients with obesity
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Sep 2015
Price :
$35
*
At a glance
- Drugs Moxonidine (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 02 Sep 2015 New trial record